Minerva Neurosciences, Inc.
NERVAs of the close on Sep 25, 2026
Price
$3.40
Market cap
—
The cover-page share count does not match the latest report's share count
P/E (diluted TTM)
—
The fourth quarter's per-share figure could not be confirmed from the annual report
EPS (TTM)
—
The fourth quarter's per-share figure could not be confirmed from the annual report
Dividend yield
—
Dividend records do not yet cover the latest payments
Figures shown here come from public SEC filings. Dates beside each section show the available history.
How Minerva Neurosciences, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Source: Minerva Neurosciences, Inc. — 10-K filed Mar 1, 2022
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 13 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 5, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Fortitude Family Office, LLC | 2026-03-31 | 303 | Not shown | SEC filing |
| Farther Finance Advisors, LLC | 2026-03-31 | 100 | Not shown | SEC filing |
| Anchor Investment Management, LLC | 2026-03-31 | 12 | Not shown | SEC filing |
| Fortitude Family Office, LLC | 2025-12-31 | 303 | Not shown | SEC filing |
| Farther Finance Advisors, LLC | 2025-12-31 | 100 | Not shown | SEC filing |
| Anchor Investment Management, LLC | 2025-12-31 | 12 | Not shown | SEC filing |
| Anchor Investment Management, LLC | 2025-09-30 | 12 | Not shown | SEC filing |
| Farther Finance Advisors, LLC | 2025-09-30 | 100 | Not shown | SEC filing |
| Anchor Investment Management, LLC | 2025-06-30 | 12 | Not shown | SEC filing |
| Farther Finance Advisors, LLC | 2025-06-30 | 100 | Not shown | SEC filing |
| Farther Finance Advisors, LLC | 2025-03-31 | 100 | Not shown | SEC filing |
| Anchor Investment Management, LLC | 2025-03-31 | 12 | Not shown | SEC filing |
| Anchor Investment Management, LLC | 2024-12-31 | 12 | Not shown | SEC filing |
| Anchor Investment Management, LLC | 2024-09-30 | 12 | Not shown | SEC filing |
| Anchor Investment Management, LLC | 2024-06-30 | 12 | Not shown | SEC filing |
- Each value is checked against Minerva Neurosciences, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 15 rows: no share price from within three months of their report dates is on file, so they could not be checked.
Filer report history
Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security.
- Anchor Investment Management, LLC: 12 shares reported 2025-12-31; 12 shares reported 2026-03-31.
- Farther Finance Advisors, LLC: 100 shares reported 2025-12-31; 100 shares reported 2026-03-31.
- Fortitude Family Office, LLC: 303 shares reported 2025-12-31; 303 shares reported 2026-03-31.
- Anchor Investment Management, LLC: 12 shares reported 2025-09-30; 12 shares reported 2025-12-31.
- Farther Finance Advisors, LLC: 100 shares reported 2025-09-30; 100 shares reported 2025-12-31.
- Anchor Investment Management, LLC: 12 shares reported 2025-06-30; 12 shares reported 2025-09-30.
- Farther Finance Advisors, LLC: 100 shares reported 2025-06-30; 100 shares reported 2025-09-30.
- Anchor Investment Management, LLC: 12 shares reported 2025-03-31; 12 shares reported 2025-06-30.
- Farther Finance Advisors, LLC: 100 shares reported 2025-03-31; 100 shares reported 2025-06-30.
- Anchor Investment Management, LLC: 12 shares reported 2024-12-31; 12 shares reported 2025-03-31.
- Anchor Investment Management, LLC: 12 shares reported 2024-09-30; 12 shares reported 2024-12-31.
- Anchor Investment Management, LLC: 12 shares reported 2024-06-30; 12 shares reported 2024-09-30.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Minerva Neurosciences, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2021-12-01 · Kupfer David: Larger than 45 of the 48 other insider sales of Common Stock on file. SEC filing
- 2019-06-24 · Index Venture Associates IV Ltd: Larger than all 48 other insider sales of Common Stock on file. SEC filing
- 2019-06-19 · Index Venture Associates IV Ltd: Larger than 47 of the 48 other insider sales of Common Stock on file. SEC filing
- 2019-06-17 · Index Venture Associates IV Ltd: Larger than 46 of the 48 other insider sales of Common Stock on file. SEC filing
- 2019-05-15 · Index Venture Associates IV Ltd: Larger than 44 of the 48 other insider sales of Common Stock on file. SEC filing
- 2017-03-20 · Beer Marc D: Larger than 16 of the 17 other insider purchases of Common Stock on file. SEC filing
- 2017-03-17 · Beer Marc D: Larger than 16 of the 17 other insider purchases of Common Stock on file. SEC filing
Independent insiders buying near the same time
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2023-05-02 | Luthringer Remy · CEO | Common Stock | S — Open market or private sale | −3,641 | 3.76 | SEC filing |
| 2023-05-01 | Luthringer Remy · CEO | Common Stock | S — Open market or private sale | −23,753 | 3.85 | SEC filing |
| 2023-05-01 | Ahlholm Frederick W · SVP, CFO and Secretary | Common Stock | S — Open market or private sale | −3,580 | 4.48 | SEC filing |
| 2023-05-01 | Race Geoff · President | Common Stock | S — Open market or private sale | −22,082 | 3.85 | SEC filing |
| 2021-12-01 | Kupfer David · Director | Common Stock | S — Open market or private sale | −55,635 | 0.88 | SEC filing |
| 2020-12-16 | Reilly Joseph H. · SVP & Chief Operating Officer | Common Stock | S — Open market or private sale | −3,228 | 2.64 | SEC filing |
| 2020-12-16 | Race Geoff · EVP, CFO & CBO | Common Stock | S — Open market or private sale | −6,190 | 2.64 | SEC filing |
| 2020-12-16 | Luthringer Remy · CEO | Common Stock | S — Open market or private sale | −1,300 | 2.64 | SEC filing |
Showing 8 of 20 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-03 | VAN HEEK G JAN · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +50,000 | SEC filing |
| 2026-06-03 | Kupfer David · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +50,000 | SEC filing |
| 2026-06-03 | Luthringer Remy · CEO | Employee Stock Option (right to buy) | A — Grant, award, or other acquisition | +1,690,700 | SEC filing |
| 2026-06-03 | Ahlholm Frederick W · SVP, CFO and Secretary | Employee Stock Option (right to buy) | A — Grant, award, or other acquisition | +680,000 | SEC filing |
| 2026-06-03 | HASLER HANS PETER · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +50,000 | SEC filing |
| 2026-06-03 | Laghrissi-Thode Fouzia · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +50,000 | SEC filing |
| 2026-06-03 | Kaul Inderjit · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +50,000 | SEC filing |
| 2026-04-21 | O'Connor James Joseph · Chief Business Officer and GC | Employee Stock Option (right to buy) | A — Grant, award, or other acquisition | +350,800 | SEC filing |
Showing 8 of 20 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2018-01-31 | Beer Marc D · Director | Stock Option (Right to Buy) | D — Disposition to the issuer | −127,513 | SEC filing |
| 2018-01-31 | Beer Marc D · Director | Stock Option (Right to Buy) | D — Disposition to the issuer | −12,500 | SEC filing |
| 2018-01-31 | Beer Marc D · Director | Stock Option (Right to Buy) | D — Disposition to the issuer | −80,356 | SEC filing |
| 2018-01-31 | Beer Marc D · Director | Stock Option (Right to Buy) | D — Disposition to the issuer | −7,500 | SEC filing |
| 2017-08-29 | JOHNSON & JOHNSON · 10% owner | Common Stock | J — Other acquisition or disposition | −3,892,256 | SEC filing |
| 2017-07-24 | Vandervelpen Nico · Director | Stock Option (Right to Buy) | D — Disposition to the issuer | −12,500 | SEC filing |
| 2017-07-24 | Vandervelpen Nico · Director | Stock Option (Right to Buy) | D — Disposition to the issuer | −25,000 | SEC filing |
Showing 7 of 7 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.